Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care

NCT02440386 is registered in ClinicalTrials.gov with University of Cape Town as lead sponsor.

NCT NCT02440386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02440386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care
Lead sponsor
University of Cape Town
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2015
Completion date
November 30, 2016
Enrollment
87 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv